China Regenerative Medicine International Limited (HKG:8158)

Hong Kong · Delayed Price · Currency is HKD

0.2320

+0.0120 (5.45%)

Aug 4, 2026, 11:43 AM HKT

HKG:8158 Financials Overview

Financials in millions HKD. Fiscal year is January - December.

Millions HKD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	72.06	72.06	90.62	69.49	41.54	282.9
Revenue Growth	23.76%	-20.48%	30.41%	67.29%	-85.32%	55.32%
Gross Profit	41.92	41.92	57.65	19.42	37.62	67.73
Operating Income	-0.44	-0.44	6.14	-26.11	11.81	61.63
Net Income	27.53	27.53	17.75	-107.7	4.56	51.83
Earnings Per Share	0.09	0.09	0.06	-0.38	0.02	0.18
EPS Growth	2107.05%	55.17%	-	-	-91.21%	-

Revenue by Segment

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Aesthetic Medical and Beauty Services	64.04	64.04	85.35
Medical Services	8.02	8.02	5.26
Total	72.06	72.06	90.62

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	8.17	8.17	22.7	3.33	1.85	9.93
Total Debt	51.31	51.31	53.69	50.19	72.01	35.82
Net Cash (Debt)	-43.14	-43.14	-30.99	-46.86	-70.16	-25.9
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-0.14	-0.14	-0.10	-0.16	-0.25	-0.09

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	4.09	4.09	18.3	10.79	-12.43	-3.02
Capital Expenditures	-0.07	-0.07	-0.63	-0.27	-2.59	-0.81
Free Cash Flow	4.02	4.02	17.68	10.52	-15.03	-3.83
Free Cash Flow Growth	70.91%	-77.23%	68.11%	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	58.17%	58.17%	63.62%	27.95%	90.58%	23.94%
Operating Margin	-0.61%	-0.61%	6.77%	-37.58%	28.42%	21.79%
Pretax Margin	21.08%	21.08%	19.59%	-154.99%	19.90%	22.73%
Profit Margin	38.20%	38.20%	19.59%	-154.99%	10.97%	18.32%
FCF Margin	5.59%	5.59%	19.51%	15.13%	-36.17%	-1.35%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 4, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	2.43	4.64	5.06	-	69.56	15.42
P/FCF Ratio	16.63	31.75	5.08	15.91	-	-
PS Ratio	0.93	1.77	0.99	2.41	7.63	2.83